ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
3,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
4,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
4,2,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
4,3,Pancreatitis necrotising,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
5,1,Sepsis syndrome,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
6,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
8,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
8,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
8,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
9,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
10,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,Y
10,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
11,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
12,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
12,2,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
13,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
13,2,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
14,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
15,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
16,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
17,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
17,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
17,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
17,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
18,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
18,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
18,3,Intertrigo,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
19,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
19,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
19,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
19,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
20,1,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
20,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
21,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
21,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
21,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
22,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
23,1,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
24,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
24,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
25,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
25,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
25,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
25,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
26,1,Tendonitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
27,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
28,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
29,1,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
30,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
31,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
32,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
33,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
34,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
